The Organoid Revolution: From Disease Models to Drug Discovery
A new review in ACS Pharmacology & Translational Science highlights the transformative potential of three-dimensional brain and cardiac organoids in translational medicine. These lab-grown, miniature tissue structures are advancing beyond basic research to become powerful tools for modeling complex diseases and accelerating the drug discovery pipeline. The article surveys current applications and future directions, positioning organoid technology as a critical bridge between preclinical studies and clinical trials.
Why it might matter to you: For gastroenterology, this technological paradigm directly parallels the rapid development of gastrointestinal organoids for modeling conditions like inflammatory bowel disease, colorectal cancer, and celiac disease. Understanding the trajectory of organoid applications in other organ systems provides a strategic roadmap for leveraging similar models in digestive health research, particularly for personalized medicine and testing novel therapeutic agents.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
